Kathleen M. Mahoney
Beth Israel Deaconess Medical Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Renal cell carcinoma treatment, CAR-T cell therapy research
Most-Cited Works
- → Combination cancer immunotherapy and new immunomodulatory targets(2015)1,325 cited
- → The importance of exosomal PDL1 in tumour immune evasion(2020)623 cited
- → The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma(2015)568 cited
- → Progressive immune dysfunction with advancing disease stage in renal cell carcinoma(2021)492 cited
- → Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade(2017)358 cited
- → VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy(2021)211 cited
- Prognostic and predictive markers for the new immunotherapies.(2014)
- → A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression(2018)137 cited
- → PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells(2015)126 cited
- → irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial(2019)120 cited